The complex interplay between the tumor microenvironment and TUBA1B could potentially modulate the efficacy of therapeutic agents, highlighting the need for a more comprehensive approach that integrates both genomic and microenvironmental factors to overcome drug resistance and optimize treatment strategies, thus offering promising improvements in personalized cancer care and outcomes. Here, TUBA1B is linked to neoplasm.